Adeshwar Meditex Limited Files Annual SEBI Disclosure Under Takeover Regulations for FY26
Adeshwar Meditex Limited submitted its annual SEBI disclosure for FY26, confirming no share encumbrance by promoters during the year. Promoters Krishnojirao Nagaraja Rao and Abhinandan Nagaraja Rao hold 40,12,000 and 43,11,332 shares respectively as of March 31, 2026. The disclosure was filed with BSE under Regulation 31(4) of SEBI takeover regulations, ensuring compliance with substantial shareholding requirements.
*this image is generated using AI for illustrative purposes only.
Adeshwar Meditex Limited has filed its mandatory annual disclosure with BSE Limited under SEBI's takeover regulations for the financial year ended March 31, 2026. The disclosure, submitted on April 7, 2026, confirms compliance with regulatory requirements regarding substantial shareholding by promoters.
Regulatory Compliance Declaration
The company's promoters have declared that no encumbrance was created over their shareholdings during the financial year ended March 31, 2026. This declaration was made in accordance with Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 2011.
Abhinandan Nagaraja Rao, Whole Time Director with DIN 08677161, confirmed on behalf of all promoters that they, along with persons acting in concert, have not made any encumbrance over shares held directly or indirectly during FY26.
Promoter Shareholding Details
As of March 31, 2026, the promoter shareholding structure shows significant holdings by key management personnel:
| Name: | Category: | Total Shares Held: |
|---|---|---|
| Krishnojirao Nagaraja Rao | Promoter | 40,12,000 |
| Abhinandan Nagaraja Rao | Promoter | 43,11,332 |
| Combined Holdings: | Promoters | 83,23,332 |
Key Personnel and Documentation
The disclosure documents were signed by both Whole Time Directors of the company:
- Krishnojirao Nagaraja Rao (DIN: 07684308) - Whole Time Director
- Abhinandan Nagaraja Rao (DIN: 08677161) - Whole Time Director
The documentation was digitally signed and submitted to BSE Limited's Department of Corporate Services at P.J. Towers, Dalal Street, Fort, Mumbai. The company operates under BSE scrip code 543309.
Corporate Governance Framework
This annual disclosure represents part of Adeshwar Meditex Limited's ongoing compliance with SEBI's substantial acquisition and takeover regulations. The filing ensures transparency in promoter shareholding patterns and adherence to regulatory frameworks governing listed companies in India.
The company's registered address is at Gala 111 Lok Centre, Marol Maroshi Road, Andheri East, Mumbai-400059, Maharashtra, India, where the audit committee also received copies of the disclosure documentation.
Will Adeshwar Meditex consider raising additional capital through equity dilution given the high promoter shareholding of over 83%?
How might the company's expansion plans be affected by the promoters' commitment to maintain unencumbered shareholdings?
What strategic partnerships or acquisitions could Adeshwar Meditex pursue in the medical textiles sector for FY27?
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
